Biotech Week back issues from December 2003:
Team developing "Flu Chip" for fast, accurate diagnosis.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A team of researchers at the University of Colorado at Boulder is developing a "Flu Chip" that will aid physicians in swiftly diagnosing respiratory illness for future flu seasons. The Flu Chip will allow doctors and public health ...
Imaging damaged brain cells in living mice provides clues to dementia.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Using recently developed techniques for imaging individual cells in living animals, a team led by researchers at Washington University School of Medicine in St. Louis has watched as Alzheimer-like brain plaques damage mouse brain cells. ...
Genetic mutations resulting in delayed puberty are focus of study.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Identifying genetic mutations that delay puberty in a small number of children may also lead to better infertility treatment and birth control, says a Medical College of Georgia physician-scientist. "Irreversible, delayed puberty is ...
Nasal or rectal administration of glycyrrhizin offers good bioavailability.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Nasal or rectal administration of glycyrrhizin offers good bioavailability. According to recent research published in the International Journal of Pharmaceutics, "the purpose of this study was to examine the improvement of the ...
Chromotest updates presented at American Society of Human Genetics meeting.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Ikonisys, Inc., a company focused on cell-based diagnostic products for the obstetrical and oncology markets, announced a major achievement in its development of Chromotest, a test to detect Down syndrome and other chromosomal abnormalities early ...
Alzhemed open-label phase II extension study demonstrates cognitive benefits.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Neurochem, Inc., (NRM) announced positive results on cognitive function as measured by ADAS-cog of patients suffering from mild-to-moderate Alzheimer Disease (AD) in an open-label phase II extension study. Neurochem is reporting on the ...
Care inconsistent for heart patients.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A third of heart failure patients left hospitals without some of the tried-and-true therapies that could add years to their lives, according to one of the largest studies of its kind, reported at the American Heart Association's Scientific Sessions ...
Pain medication maker reports royalty income increased 23%.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended September 30, 2003, reflecting increased royalty income and contract revenues. A.P. Pharma reported that total revenues for the third quarter of 2003 increased ...
Polymorphisms in DNA repair genes may be linked to immunosuppression, cancer.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Polymorphisms in DNA repair genes may be linked to immunosuppression, cancer. "When the sun damages the skin, it also impairs the DNA. The DNA repair system is needed to maintain the genetic integrity of the epidermis. Defects in DNA ...
Motion Media forges alliance with telemedicine company.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Motion Media Technology (MMD) announced a strategic distribution alliance with AMD Telemedicine, a provider of medical devices for the telemedicine market. As part of this alliance, Motion Media's videophone solutions for telemedicine ...
Neugene maker reports net loss of $0.15 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 and 9 months ended September 30, 2003, and provided an update on its clinical pipeline. For the third quarter of 2003, the company reported a net loss of $4.6 million, or ...
Elevated cytokine levels in adipose tissue suppress adiponectin output in HALS patients.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Elevated cytokine levels in adipose tissue suppress adiponectin activity in HIV lipodystrophy patients. According to published research from Denmark, "Human immunodeficiency virus (HIV)-associated lipodystrophy syndrome (HALS) is a side ...
Negative effects of saquinavir hard gel treatment subside over time.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The negative effects of saquinavir hard gel treatment on the overall outcome of HIV therapy subside over time. "Saquinavir hard gel capsule (hgc), the first human immunodeficiency virus (HIV) protease inhibitor (PI) used in clinical ...
Cell therapy company launches direct stock purchase program.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that registered shareholders of the company can purchase up to an aggregate of 10 million newly issued shares of its stock through Aastrom's Direct Stock Purchase Program (DSPP), unless otherwise noted in ...
Glucerna weight loss shakes for people with diabetes wins award.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories' (ABT) Ross Products Division announced that Glucerna Weight Loss Shakes were judged to be the overall Best Taste Award winner by the professional chefs of the American Culinary Institute. Glucerna Weight Loss Shakes ...
Generic drug maker reports 38.9% increase in sales.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX, AAB) announced financial results for the 3 months ended September 30, 2003. For the third quarter of 2003, the company reported net sales of $20.9 million, a 38.9% increase compared to net sales of $15.0 ...
Molecular assay enables rapid, accurate detection of mutant mycobacterial katG.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A novel real-time polymerase chain reaction (PCR) assay can quickly and accurately identify TB strains carrying katG resistance mutations. "The emergence of drug-resistant strains of Mycobacterium tuberculosis is a serious public health ...
First human trial of West Nile vaccine to begin.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Acambis (ACAM) announced the start of a phase I trial of its investigational vaccine against West Nile virus, ChimeriVax-West Nile. Since it was first identified in New York in 1999, the West Nile virus has swept through 45 U.S. states, ...
Assay maker reports loss of $0.14 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aclara BioSciences (ACLA) reported financial results for the 3 months ended September 30, 2003. Revenue for the 3 months ended September 30, 2003, was $276,000, compared to revenue for the 3 months ended September 30, 2002, of $505,000 ....
The LeJour vertical mammoplasty pattern for skin-sparing mastectomy.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The LeJour vertical mammoplasty pattern for skin-sparing mastectomy. According to recent research published in the journal Annals of Plastic Surgery, "An application of the LeJour vertical mammoplasty skin pattern for skin-sparing mastectomy is ...
Two patents granted for treatment of inflammatory diseases.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC, announced the issue of two United States patents for the treatment of a wide-ranging group of inflammatory diseases with adenosine A2A agonists. The patents are 6,531,457 and 6,514,949, Methods and ...
Pain management drug maker announces pricing of common stock.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced the pricing of a public offering of 6,000,000 shares of its common stock at $17.25 per share. The gross proceeds from the offering are expected to be $103.5 million. All of the shares are being offered ...
Ophthalmology company completes purchase of manufacturing facility.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Advanced Medical Optics, Inc., (AMO, AVO) announced that its Spanish subsidiary has completed the purchase of an existing manufacturing facility in Madrid, Spain, from Alcon CUSI, S.A., a subsidiary of Alcon, Inc. AMO paid approximately ...
Sheep are useful models for studying bone density.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Sheep are useful models for studying bone density. According to a study from New Zealand, "bone density (BD) is an important factor in osteoporotic fracture risk in humans. However, BD is a complex trait confounded by environmental ...
NHGRI funds large-scale genomic sequencing project.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corp., a provider of genomic services and nucleic acid purification products to the life sciences industry, announced that it has been awarded a grant from The National Human Genome Research Institute (NHGRI) of the U.S ....
First 60-mer microarray for rice commercialized.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A), in collaboration with Japan's National Institute of Agrobiological Sciences (NIAS), has commercialized the first 60-mer oligonucleotide microarray for the study of rice, a staple food for half the world's ...
Cre-mediated recombination efficiency determinable with immediate visual system.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Cre-mediated recombination efficiency can be determined using an immediate visual system prior to full examination of the phage library created. "Diversity in phage antibody libraries is important for obtaining useful high-affinity ...
Reactive oxygen species exacerbate the effects of hepatitis B virus X protein.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Reactive oxygen species exacerbate the effects of hepatitis B virus X protein. According to published research from South Korea, "HBx (hepatitis B virus X) viral oncoprotein is a multifunctional protein of which the cellular level may be ...
Menstrual cycle influences baroreflex heart rate control.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Baroreflex regulation of cardiac activity is influenced by the menstrual cycle in women. Researchers in Japan conducted a study "to determine baroreflex control of heart rate (HR) to hypotensive and hypertensive stimuli during the early ...
Hemodialysis company reports per share loss of $0.19.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aksys, Ltd., (AKSY) reported results for the quarter ended September 30, 2003. For the third quarter of 2003, Aksys reported total revenues of $411,000 compared to $169,000 for the third quarter of 2002. Product revenues for the quarter ...
Device company's executives enter into Rule 10b5-1 trading programs.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Alaris Medical Systems, Inc., (AMI) announced that several executives, including David L. Schlotterbeck, president and chief executive officer, have adopted pre-arranged trading plans permitted under the securities laws to sell limited amounts of ...
Chemistry drug company reports 41.6% increase n revenue.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Albany Molecular Research, Inc., (AMRI) reported financial results for the quarter and 9-month period ending September 30, 2003. Total revenue for the third quarter of 2003 increased by $13.3 million, or 41.6%, to $45.4 million, compared ...
Drug delivery company reports loss of $0.31 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the 3-month period ended September 30, 2003. The net loss on a GAAP basis for the quarter ended September 30, 2003, was $26.2 million or $0.31 per share as compared to a net loss ...
MRI useful for detecting asymptomatic spinal arachnoiditis in TBM patients.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Magnetic resonance imaging (MRI) is a valuable tool for detecting asymptomatic spinal arachnoiditis in tuberculous meningitis (TBM) patients. "Spinal arachnoiditis is one of the common and disabling complications" of TBM, scientists in ...
Oncology company reports loss of $0.19 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) reported financial results for the third quarter of 2003. For the 3 months ended September 30, 2003, the company reported a net loss of $5.0 million, or $0.19 per share, compared to a net loss of $5.3 ...
510k market clearance granted for catheters with thermal regulation system.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Alsius Corp. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ICY and Fortius Catheters in combination with the CoolGard 3000 Thermal Regulation System. The products are ...
Pharmaceutical company boosts sales by 13% worldwide.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Altana AG (AAA; ALT) reported sales of around EUR 2 billion for the first 9 months of 2003, up 5% on the equivalent previous year's figure. "Despite the worldwide economic slump, the weak dollar, and health-policy measures, we have ...
Phase I/II study initiated treating diabetes with encapsulated replacement islets.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AmCyte, Inc., announced the initiation of a phase I/II clinical safety trial treating diabetic patients with transplanted replacement islets without long-term immune suppression. Patient enrollment is commencing in the trial entitled: ...
Data: SPARC Sling System is a safe and effective treatment for women.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Landmark 12-month data presented at the International Urogynecological Association meeting in Buenos Aires, Argentina, provides the strongest evidence to date that American Medical System's (AMMD) innovative SPARC Sling System offers women a safe ...
Caesarean delivery impacts younger infants with hyaline membrane disease.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Caesarean delivery impacts younger infants with hyaline membrane disease. "A hospital-based case-control study was conducted to examine the relationship between hyaline membrane disease (HMD) and caesarean route of delivery, in light of ...
Lilly purchases integrated cellular screening system.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Amersham (AHM) announced that Eli Lilly and Co. (LLY) has purchased an integrated suite of cellular screening technology and licenses to help in the identification of potential therapeutics in its drug discovery program. In addition to ...
Custom lab system designed for breast cancer project.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Amersham Biosciences, the life sciences business of Amersham (AHM), has signed an agreement with the Windber Research Institute to develop a customized Scierra Solutions Laboratory Workflow System to manage the data generated in its Clinical Breast ...
Medarex announces achievement of milestone in agreement.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) has achieved a significant milestone under its 1999 agreement with Amgen, Inc. The achievement of this milestone will trigger an undisclosed payment to Medarex. "We are pleased to add Amgen to the ...
Metabolic disease drug maker reports loss of $0.40 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported financial results for the third quarter ended September 30, 2003. The company reported a net loss of $37.5 million, or $0.40 per share, and $105.5 million, or $1.15 per share, for the 3 and 9 ...
FDA approval granted for loratadine.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that the U.S. Food and Drug Administration (FDA) has approved the marketing of its Abbreviated New Drug Application (ANDA) for its loratadine orally disintegrating tablets 10mg, which are bioequivalent to Schering ...
Tissue, bone repair company posts 27% increase in revenue.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Anika Therapeutics, Inc., (ANIK) announced financial results for the third quarter and 9-months ended September 30, 2003. For the third quarter, Anika posted revenue of $3,688,000, a 27% increase, compared with $2,905,000 for the same ...
Animas IR 1200 receives FDA approval.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Animas Corporation has received approval from the U.S. Food and Drug Administration (FDA) for the Animas IR 1200 insulin pump. This approval marks a major milestone for Animas, as well as the diabetes industry. The IR 1200 is the ...
Data on AMD3100 to be presented at ASH.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced that a number of clinical and preclinical abstracts on AMD3100, a rapid and potent stem cell mobilizer, have been accepted for presentation at the American Society of Hematology (ASH) annual meeting being held in San ...
Two new members added to board at drug delivery company.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that two new members have joined its Board of Directors effective October 31, 2003. Anton Gueth was elected to a 3-year term at the Annual Meeting of Shareholders held on October 31, 2003, and ...
Eric von Hofe named VP of technology development.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology, Inc., (GNBT) announced that its Antigen Express subsidiary for developing novel immunomedicines has appointed Eric von Hofe, PhD, as vice president of technology development effective immediately. von Hofe was ...
Immunotherapeutics company hires new VP.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced that Renu Gupta, MD, has joined the company as senior vice president of development, a new position that will be responsible for regulatory affairs, clinical development, and program and portfolio management. ...
Broad potential reported for R1549 highlighted by favorable tolerability profile.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Antisoma plc, announced final results from its pilot phase II study of R1549 in gastric cancer. The trial, which has been funded since November 2002 by Antisoma's co-development partner, Roche, evaluated the drug in a small group of ...
Memorial Sloan-Kettering signs with telemedicine company.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Apollo Telemedicine, Inc., announced that Memorial Sloan-Kettering Cancer Center is installing its dynamic telediagnostic systems to create real-time visual connection between the pathologist in the laboratory and the surgeons in the operating ...
Genome-wide human genetic variation map complete.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Applied Biosystems Group (ABI), an Applera Corporation business, announced that it has completed the development of a genome-wide human genetic variation map based on single nucleotide polymorphisms (SNPs) and introduced a free, downloadable ...
Alliance with the Cleveland Clinic uses imaging system in cancer research.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. announced the formation of a clinical research imaging collaboration with the Department of Anatomic Pathology at The Cleveland Clinic Foundation. As part of this collaboration, The Cleveland Clinic has purchased ...
Insulin system maker reports loss of $0.08 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM) announced financial results for the third quarter and 9 months ended September 30, 2003. Contract revenues for the quarter were $9.8 million, compared to $6.0 million for the same period in 2002. The majority ...
Biotech company reports loss of $0.21 per share.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the first quarter of fiscal 2004, ended September 30, 2003. During the first quarter of fiscal 2004, Array reported total revenue of $7.2 million, compared to $10.5 million ...
Low infection rate seen in Arrow Lionheart European trial.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The results of the first study of the Arrow LionHeart, a heart assist device conceived of and developed at Penn State College of Medicine in cooperation with Arrow International, Inc., show low incidence of infection and few device failures. ...
Clinical mass spectrometry in neuroscience proteomics reviewed.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Researchers have reviewed the application of clinical mass spectrometry to the areas of proteomics and peptidomics in neuroscience. According to a study from Sweden, "In this review we discuss the merits and drawbacks with the use of ...
Warfarin efficacy matched by new thrombin inhibitor ximelegatran.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- by Richard Hyer, NewsRx correspondent - In the largest trial of atrial fibrillation ever conducted, the new oral direct thrombin inhibitor ximelegatran compared favorably with dose-adjusted warfarin in almost all categories, according to data ...
Inflammatory diseases drug maker files resale registration statement with SEC.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) announced that it has filed a resale registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) pertaining to its Convertible Notes issued on August 19, 2003. AtheroGenics filed ...
Richmond to resume duties as interim CFO at drug delivery firm.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that Brian G. Richmond, the company's former chief financial officer, will serve as interim chief financial officer. In August, the company announced the appointment of Mark A. Wallace as chief ...
Allogeneic RIST could be outpatient procedure.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Reduced intensity stem cell allotransplantation can be feasibly performed as an outpatient procedure. "Allogeneic stem cell transplantation (allo-SCT) after a reduced-intensity conditioning (RIC) protocol is associated with decreased ...
High-dose methadone linked to QT prolongation and Torsades de Pointes in HIV patients.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- High-dose methadone therapy may cause QT prolongation and Torsades de Pointes in HIV patients. According to published research from Spain, "Four patients infected with human immunodeficiency virus receiving antiretroviral treatment and ...
AlphaNet to provide services to emphysema patients who rely on Zemaira.
Dec 03, 2003 ... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aventis Behring, LLC, announced an agreement with AlphaNet, Inc., a not-for-profit health management company, to provide health management and support services to patients who rely on Zemaira (alpha1-proteinase inhibitor (human)). In ...